SEVERE CANDIDIASIS ASSOCIATED WITH THYMIC DYSPLASIA, IgA DEFICIENCY, AND PLASMA ANTILYMPHOCYTE EFFECTS
1 Pediatric Service, Walter Reed General Hospital, Department of Hematology, Walter Reed Army Institute of Research and Department of Pediatrics, Georgetown University School of Medicine, Washington, D.C.
Evidences of impaired cell-mediated immunity were found in a boy having mucocutaneous candidiasis and chronic pulmonary disease. The thymus gland and peripheral lymphatic tissues were dysplastic. IgA was absent from serum and secretions. The patient's plasma clumped leucocytes in suspension, an effect enhanced by bovida antigens. In vitro lymphocyte transformation, proliferation, and replication were normal in systems free of patient plasma but were partially inhibited by his plasma and totally inhibited by his plasma and bovida antigens. Large amounts of antibovida antibodies were found in the patient's plasma; and, when they were removed, lymphocyte functions were partially restored, even in the presence of bovida antigens. A plasma lymphocvtotoxic assay was positive. This appears to be a distinct syndrome comprising thymic dysplasia, IgA deficiency, antibovida antibodies, various types of plasma-mediated antilymphocyte effects, defective cellular and humoral immunity, and severe candidiasis.
Submitted on September 12, 1969Accepted on February 2, 1970
This article has been cited by other articles:
![]() |
E. I. Ette, P. J. Williams, Y. H. Kim, J. R. Lane, M.-J. Liu, and E. V. Capparelli Model Appropriateness and Population Pharmacokinetic Modeling J. Clin. Pharmacol., June 1, 2003; 43(6): 610 - 623. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Vermes, H.-J. Guchelaar, and J. Dankert Flucytosine: a review of its pharmacology, clinical indications, pharmacokinetics, toxicity and drug interactions J. Antimicrob. Chemother., August 1, 2000; 46(2): 171 - 179. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. R. Brown, B. F. Mackler, B. M. Levy, T. E. Wright, S. F. Handler, J. S. Moylan, D. H. Perkins, and H. J. Keene Comparison of the Plaque Microflora in Immunodeficient and Immunocompetent Dental Patients Journal of Dental Research, December 1, 1979; 58(12): 2344 - 2352. [Abstract] [PDF] |
||||
![]() |
J. E. BENNETT Flucytosine Ann Intern Med, March 1, 1977; 86(3): 319 - 322. [Abstract] [PDF] |
||||
![]() |
R. Meyer and J. L. Axelrod Fatal Aplastic Anemia Resulting From Flucytosine JAMA, June 17, 1974; 228(12): 1573 - 1573. [Abstract] [PDF] |
||||
![]() |
C. H. KIRKPATRICK and T. K. SMITH Chronic Mucocutaneous Candidiasis: Immunologic and Antibiotic Therapy Ann Intern Med, March 1, 1974; 80(3): 310 - 320. [Abstract] [PDF] |
||||
![]() |
E. R. STIEHM, A. J. AMMANN, E. V. BARNETT, C. G. CRADDOCK, H. H. FUDENBERG, and G. J. LAWLOR JR. Diseases of Cellular Immunity Ann Intern Med, July 1, 1972; 77(1): 101 - 116. [Abstract] [PDF] |
||||
![]() |
J. S. REMINGTON Toxicity of 5-Fluorocytosine Ann Intern Med, May 1, 1972; 76(5): 830 - 831. [Abstract] [PDF] |
||||
![]() |
L. F. Montes, M. D. Cooper, L. G. Bradford, R. O. Lauderdale, and C. D. Taylor Prolonged Oral Treatment of Chronic Mucocutaneous Candidiasis With Amphotericin B Arch Dermatol, July 1, 1971; 104(1): 45 - 56. [Abstract] [PDF] |
||||
![]() |
C. H. KIRKPATRICK, R. R. RICH, and J. E. BENNETT Chronic Mucocutaneous Candidiasis: Model-Building in Cellular Immunity Ann Intern Med, June 1, 1971; 74(6): 955 - 978. [Abstract] [PDF] |
||||










